New Research Poster Presentation 3.24: Twenty-Four Month Effectiveness of Guanfacine Extended Release in Children and Adolescents Aged 6 to 17 Years with ADHD

Thursday, October 29, 2009 12:30 PM

Floyd Sallee, M.D., Ph.D., University of Cincinnati, Cincinnati, OH

Keith McBurnett, Ph.D., University of California at San Francisco, San Francisco, CA

Timothy Wigal, Ph.D., University of California at Irvine, Irvine, CA

Andrew Lyne, M.S.C., Biometrics, Shire Pharmaceuticals Inc., Basingstoke, United Kingdom

Sharon Youcha, M.D., Shire Pharmaceuticals Inc., Wayne, PA

Jonathan Rubin, M.D., M.B.A., Shire Pharmaceuticals Inc., Wayne, PA

		56th Annual Meeting Tentative Program Schedule
		Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 3.24 Twenty-Four Month Effectiveness of Guanfacine Extended Release in Children and Adolescents Aged 6 to 17 Years with ADHD